(SVRA) Savara - Performance -35.5% in 12m
Compare SVRA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
11.96%
#29 in Group
Rel. Strength
21.78%
#6224 in Universe
Total Return 12m
-35.47%
#75 in Group
Total Return 5y
28.80%
#32 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -21.35%
(?) Percentile in Group
12m Total Return: SVRA (-35.5%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: SVRA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SVRA
Total Return (including Dividends) | SVRA | XBI | S&P 500 |
---|---|---|---|
1 Month | 23.85% | 11.81% | 13.81% |
3 Months | 15.41% | -13.61% | -6.30% |
12 Months | -35.47% | -12.29% | 10.65% |
5 Years | 28.80% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | SVRA | XBI | S&P 500 |
1 Month | 69.9% | 72.9% | 83% |
3 Months | 73.1% | -83% | -75.3% |
12 Months | -85.1% | -51.6% | 50.1% |
5 Years | 70.2% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #65 | 10.8% | 8.82% |
3 Month | #19 | 33.6% | 23.2% |
12 Month | #75 | -26.4% | -41.7% |
5 Years | #32 | 71.5% | -38.0% |
FAQs
Does SVRA Savara outperforms the market?
No,
over the last 12 months SVRA made -35.47%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months SVRA made 15.41%, while XBI made -13.61%.
Over the last 3 months SVRA made 15.41%, while XBI made -13.61%.
Performance Comparison SVRA vs Indeces and Sectors
SVRA vs. Indices SVRA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.41% | 10.0% | -14.0% | -46.1% |
US NASDAQ 100 | QQQ | -2.60% | 6.49% | -14.2% | -47.1% |
US Dow Jones Industrial 30 | DIA | -2.82% | 13.9% | -13.7% | -43.2% |
German DAX 40 | DAX | -2.39% | 8.89% | -40.2% | -61.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | -4.59% | 12.0% | -14.7% | -42.8% |
Hongkong Hang Seng | HSI | -5.58% | 3.92% | -22.3% | -49.2% |
India NIFTY 50 | INDA | 2.51% | 19.0% | -14.4% | -35.3% |
Brasil Bovespa | EWZ | -3.46% | 6.61% | -22.7% | -27.1% |
SVRA vs. Sectors SVRA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -3.05% | 10.4% | -21.0% | -57.0% |
Consumer Discretionary | XLY | -2.79% | 9.62% | -13.0% | -49.7% |
Consumer Staples | XLP | -1.55% | 17.3% | -20.9% | -44.6% |
Energy | XLE | -2.23% | 17.1% | -7.36% | -26.0% |
Financial | XLF | -3.51% | 10.3% | -21.1% | -57.9% |
Health Care | XLV | 0.60% | 23.0% | -8.96% | -31.4% |
Industrial | XLI | -4.10% | 7.03% | -15.4% | -46.5% |
Materials | XLB | -2.21% | 10.3% | -9.06% | -30.2% |
Real Estate | XLRE | -1.09% | 12.3% | -14.7% | -50.9% |
Technology | XLK | -3.49% | 2.63% | -11.1% | -42.6% |
Utilities | XLU | -2.46% | 14.3% | -21.6% | -52.9% |
Aerospace & Defense | XAR | -4.39% | 2.69% | -25.5% | -62.8% |
Biotech | XBI | 4.18% | 12.0% | 6.19% | -23.2% |
Homebuilder | XHB | -2.88% | 12.4% | -0.76% | -27.9% |
Retail | XRT | -4.31% | 9.20% | -9.71% | -34.0% |